Category: Congress Info

Iddo Nadav Weiner, VP of Research at BiomX, Israel presented a short oral talk entitled “A Phase 1b/2a Randomized, Double-blind, Placebo-controlled Study Evaluating Nebulized Phage Therapy in Cystic Fibrosis Subjects With Chronic Pseudomonas Aeruginosa Pulmonary Infection ” during Targeting Phage Therapy 2023 on June 1-2 in Paris. Dr. Weiner will describe the development of a…

Adam Ostrowski, Cellexus, United Kingdom presented a short oral talk entitled “Implementing GMP Manufacturing for Phage Therapy” during Targeting Phage Therapy 2023 on June 1-2 in Paris. The CellMaker single use, airlift bioreactor is an ideal fermentation system for phage production in a GMP environment. The patented airlift technology provides excellent mixing and aeration kinetics…

Targeting Phage 2023: Questions, Controversies, & What is Next? Targeting Phage Therapy 2023 will highlight the recent innovations and clinical applications of phages, validation and limitations. Targeting Phage Therapy 2023 will also cover how phages will transform the medicine of tomorrow. More Than Just Scientific Knowledge at Targeting Phage Therapy 2023: The regulation and legal…

  During the 6th World Conference on Targeting Phage Therapy, a session will be dedicated to the latest innovations in the field of phages and phage therapy. If you are academics, industrialists or representatives of startups, the scientific committee of Phage Therapy 2023 invites you to present your latest innovation in 10 minutes. The topics…

  The 6th World Congress on Targeting Phage Therapy is to be held again on June 1-2, 2023 in Paris, France. The major aim behind  Targeting Phage Therapy 2023 is to cover the aspects of phage therapy today, especially with the emergence of antibiotic resistance. It will also shed light on the new bacteriophage-based innovations and discoveries. …